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In preparation for a clinical trial of therapeutic agents for children with moderate-to-severe blunt 
traumatic brain injuries (TBIs) in emergency departments (EDs), we conducted this feasibility 
study to 1) determine the number and clinical characteristics of eligible children, 2) determine 
the timing of patient and guardian arrival to the ED, and 3) describe the heterogeneity of TBIs on 
computed tomography (CT) scans. 
METHODS 
We conducted a prospective observational study at 16 EDs of children ≤ 18 years of age 
presenting with blunt head trauma and Glasgow Coma Scale (GCS) scores of 3-12.  We 
documented the number of potentially eligible patients, timing of patient and guardian ariv l,
patient demographics and clinical characteristics, severity of injuries, and cranial CT findings.  
RESULTS 
We enrolled 295 eligible children at the 16 sites over 6 consecutive months. Cardiac arrest and 
non-survivable injuries were the most common characteristics that would exclude patients from a 
future trial. Most children arrived within 2 hours of injury, but most guardians did not arrive until 
2-3 hours after the injury. There was a substantial range in types of TBIs, with subdural 
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CONCLUSION 
Enrolling children with moderate-to-severe TBI into time sensitive clinical trials will require 
large numbers of sites, meticulous preparation and coordination, and will prove challenging to 
obtain informed consent given the timing of patient and guardian arrival. The Federal Exception 
from Informed Consent for Emergency Research will be an important consideration for enrolling 
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Traumatic brain injury (TBI) is the leading cause of death and permanent disability from trauma 
in children.1,2  Among children 0-14 years in the United States, TBI results in an estimated 2,600 
deaths, 37,000 hospitalizations and more than 500,000 emergency department (ED) visits.3,4 
Despite the frequency of TBI, its substantial impact on the health of children, and decades of 
research on the topic, there are no proven effective treatments for TBI.5-7   
 
Many previous therapeutic trials for TBI in both children and adults have failedor several 
reasons, including: 1) the small number of patients with moderate-to-severe TBI available to be 
studied at any one center, 2) the heterogeneity of TBIs, and difficulty in controlling for this 
heterogeneity, 3) the variability in intra- and inter-institutional approaches to the treatment of 
patients with TBIs, 4) the difficulty in enrolling subjects within the therapeutic window of a 
treatment, and 5) ethical and regulatory obstacles associated with research in emergency settings, 
including the difficulty in obtaining timely written informed consent.5-9  In addition, legal 
guardians are frequently not available in the narrow therapeutic window of potential therapies. 
Therefore, the Federal Exception from Informed Consent (EFIC) (21 CFR 50.24) may be 
necessary to study time sensitive interventions in a clinical trial.10-12  Pre-clinical work has 
shown that the sooner (many) therapies are delivered to patients with TBIs, the better the 
outcomes. (REFS) There is an ongoing international multicenter pragmatic trial of tranexamic 
acid (TXA) for TBI in adults (CRASH III) where patients are randomized to TXA therapy within 
8 hours of injury.1314  In this international trial, patients who are incapable of giving consent in 
emergency situations are considered an exception to the general rule of informed consent per the 
Declaration of Helsinki.14,15 There have been other recent large interventional ED-based trials of 
progesterone for TBI in adults (ProTECT III and SyNAPSe) worth noting (and both were 
stopped for futility) .16,17   In ProTECT III, study drug was administered to adult patients wihin a 
4-hour window using EFIC.16  There are several examples of pediatric TBI trials, that failed to 
accrue sufficient numbers of children due to several factors such as limited numbers of eligible 
children at any one site, difficulties with informed consent, and arrival of subjects outside the 
therapeutic window of the study intervention.5,8  The obstacles to successful pediatric TBI trials 
have not been sufficiently addressed or overcome. Given the history of prior unsuccessful 
pediatric TBI trials, it is necessary to conduct pretrial feasibility planning work to maximize the 
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Conducting large clinical trials in head-injured children is difficult and requires a 
multidisciplinary approach.5,19  The Pediatric Emergency Care Applied Research Network 
(PECARN) was established to overcome the barriers of conducting research pertaining to acutely 
ill and injured children during all phases of emergency care and has a history of successful 
completion of large multicenter clinical trials.20-27  Due to the promising pre-clinical and phase II 
studies for the use of progesterone for adult TBI, PECARN investigators were fund d to conduct 
feasibility planning for a clinical trial of progesterone and other promising agents for TBI in 
children.28  In this manuscript we report a prospective observational feasibility study of children 
with moderate-to-severe TBI presenting to 16 pediatric EDs across the US.  
The goals of this study were to 1) determine the number and clinical characteristics of children 
with moderate-to-severe TBI at each participating site, 2) determine the timing of patient and 
guardian arrival to the ED to provide informed consent within the therapeutic windows of 




Study design and setting 
We conducted a prospective observational study at 16 level-one pediatric trauma center EDs in 
PECARN. During the 9-month study period (July 2011 – Mar 2012) each site collected data on 
all potential eligible patients for 6 consecutive months.  
Population 
We prospectively enrolled children up to their 18th birthdays who presented to the ED after blunt 
head trauma with Glasgow Coma Scale (GCS) scores of 3-12 (i.e. moderate-to-severe TBI). 
Study data collection 
We collected clinical data using a study case report form including information about patient 
demographics, mechanisms of injury, clinical presentation including GCS, and time of arrival of 
patient and legal guardian.  (See appendix 1 study case report form) All site PIs and research 
coordinators were trained on study methods using a combination of web-bas d presentations and 
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Clinicians and research staff completed most ca e report forms prospectively.  To minimize 
missed enrollment of eligible children, research staff screened daily for all patients with blunt 
head trauma and GCS scores of 3-12, then identified and retrospectively enrolled eligible 
children who had been missed. Physicians and research coordinators also recorded time of arrival 
of legally-authorized guardians.  The purpose of recording guardian arrival time was to estimate 
a time window in which written informed consent could likely be obtained from a guardian in a 
future interventional trial.  We asked site investigators to identify the best way to record the time 
of arrival of the legal guardian in advance of study initiation.  Some sites recorded time of arrival 
from their trauma record and other sites used the time of arrival as recorded by social work.  The 
site principal investigator (PI) or research staff member obtained the information from the 
treating clinician or from the medical records and did not approach the parent or patient for any 
information. Site research coordinators entered the data into n electronic data capture system 
maintained at the PECARN data center at the University of Utah.  
 
To determine the spectrum of TBIs, each site submitted cranial CT findings for each patient 
enrolled in the study. The study PIs (RS, NK) reviewed radiology reports, classified and 
adjudicated study CT findings.  For children with normal cranial CT scans, we asked site PIs to 
verify whether there was indeed a history of blunt head trauma; if there was no history of head 
trauma, these children were excluded from the database. Thr e children met this exclusion 
criterion. 
 
Study definitions  
In this analysis we used the following study definitions: 
• Best GCS score:  This was the best GCS that the patient had during their ED stay;
• Moderate TBI: GCS 9-12 inclusive;  
• Severe TBI: GCS 3-8 inclusive;  
• Non-survivable injury: This was based on the clinical judgment of the ED treating 
physician;  
• Hypotension: Documented systolic blood pressure (SBP) below 90mmHg for patients > 
10 years, <70mmHg + (age in years x 2) for patients 1- 10 years and < 70mmHg for 
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• Hypoxia: Documented oxygen saturation of < 90% for at least 15 consecutive minutes; 
• Potential Abusive Head Trauma: Assault documented as the mechanism of injury in a 
patient < 3 years-old. 
 
Human subjects protection 
As this was a minimal risk study, and because it was not practical to request informed consent 
from each patient, we requested a waiver of informed consent. There was no interactio  with the 
patients or guardians, and the scientific validity of the study was dependent on capuring the 
information from the entire population of children with moderate-to-severe TBI at each 




We prepared data summaries using SAS software (version 9.4, SAS Institute Inc., Cary, NC). 
 
RESULTS 
We enrolled 295 children with blunt head trauma and GCS scores of 3-12 during the study 
period at the 16 EDs.  All eligible patients were captured. The cumulative total of all pediatric 
ED visits to the 16 participating EDs during the study period was approximately 483,426. 
 
Table 1 describes patient demographics and mechanisms of injury, stratified by best GCS score 
in the ED. Of note, most enrolled patients were boys, and motor vehicle collisions (MVCs) were 
the most common mechanism of injury.  One-half of the patients were transferred from another 
hospital to the participating ED. Of note, 180 (61%) children were intubated at the time of the 
best GCS in the ED, making neurological assessment difficult.  In addition, 23% (67/295) of 
enrolled children received intracranial pressure (ICP) monitoring, including only one-third 
(59/196) of the severely injured. 
 
We enrolled between 5 and 34 patients per ED over the 6-month period. Figure 1 shows the 
overall ED volume of each site over the 6-month study period and numbers of patients enrolled 
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institutions.  Importantly, 77 (26%) of the 295 head-injured children in our study met one or 
more potential exclusion criteria for a future trial of TBI therapy. 3,6,21  Clinical characteristics 
that would make patients potentially ineligible for a future TBI trial are described in Table 2. The 
most common among these were cardiac arrest requiring cardiopulmonary resuscitation (CPR) 
prior to arrival to the ED and non-survivable injury determined in the ED. Age-adjuste  
hypotension was noted in 9% of patients, hypoxia in 4% and potential abusive head trauma in 6 
% (as noted by the mechanism “assault” for children younger than 3 years).  
  
Table 3 shows the timing of arrival of the child and the legal guardian after the time of injury.  
This result was stratified by whether the child was transferred from another hospital to the 
PECARN hospital, or whether the child arrived from the field to the PECARN hospital. Overall 
most children with TBIs arrived within 1-2 hours of their injuries, however, most 
parents/guardians did not arrive until 2-3 hours or later after the injury (and some guardians 
[n=8; 3%] did not arrive at all).  Of importance, 50% of children were transferred from another 
hospital and only 44% of transferred children arrived within 2-3 hours of their injury; most of 
their guardians did not arrive until 4-5 hours after injury, which has substantial implications for 
informed consent for time-sensitive therapies. We also looked at timing of guardian arrival based 
on mechanism of injury and GCS score and we found that a higher percentage of guardians 
arrived 3 or more hours after injury for the more severely injured children and for children 
involved in MVCs. 
 
The description and distribution of TBIs on CT are provided in Table 4. There was great 
heterogeneity in types of TBIs, with subdural hemorrhage being the most common intra-cranial 
injury, followed by subarachnoid hemorrhage. Of note, one-third of CT scans were normal. 
 
DISCUSSION  
In this study we documented the number of children with moderate-to-s vere TBIs presenting to 
individual EDs in PECARN and demonstrated great variation in numbers between sites. In 
addition, up to one-quarter of these children might be excluded from a clinical trial because they 
met potential exclusion criteria. When we considered only those children with severe TBIs, less 
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between the time of the patients’ arrival and that of their guardians, with most patients arriving in 
the treating ED within 1-2 hours of their injuries and most guardians not arriving 2-3 hours or 
later after the injuries. Importantly, guardians of children who were transferred from other 
hospitals took twice as long to arrive to the study hospitals than non-transferred children’s’ 
guardians. We also showed great heterogeneity of TBIs on CT and up to one-third of children 
had normal initial CT scans. 
 
Notably, we also found that the number of potential future study patients does not correlate with 
total ED patient volume, highlighting the differences in the types of patients seen between 
pediatric EDs. There was substantial variation in the numbers of patients with moderate-to-
severe TBI presenting to individual pediatric trauma centers and this variation was not related to 
overall ED volume. This demonstrates that site selection is critical to reach adequate sample 
sizes in future interventional trials of TBI in children. This issue may partially account for the 
lack of adequate patient accrual in prior pediatric TBI trials.5-8   
 
We collected data on controversial potential exclusion criteria for pediatric TBI trials (Table 2). 
These include age-adjusted hypotension, hypoxia and suspected abusive head trauma. Prior 
studies have typically excluded children with these conditions for fear of biasing the sample 
given that outcomes after TBI have been shown to be worse after a single episode of hypotension 
or hypoxia.5,8,29  The patient history in children with suspected abusive head trauma may be 
unreliable, and it may not be possible to accurately determine the time of injury. Despite these 
issues, and given both the lack of any proven effective treatments for pediatric TBI and the 
number of children with TBIs who suffer from hypotension, hypoxia or abusive head trauma, 
one may argue about the ethics of excluding these children from a future clinical trial of a 
promising therapeutic agent for TBI.  
 
Published guidelines recommend ICP monitoring for the management of children with severe
TBIs.30   In the current study, however, we found that lessthan one-third of children presenting 
to the ED with GCS scores of 8 or less subsequently had ICP monitors placed during their 
hospital stay.  Prior studies have shown significant between-sit  variations in ICP monitor 
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study may reflect that head-injured children with low GCS scores due to intubation with 
pharmacological sedation and paralysis may have been found not to have severe TBI when the 
sedation and paralysis were reversed; the relative infrequency of ICP monitor use may also 
reflect practice variation between physicians. Therefore, in future pediatric TBI clinical trials 
conducted in the ED it may be important to consider timely reversal of paralysis and sedation to 
determine the true GCS score, or to accurately determine the GCS score in the prehospital setting 
prior to paralysis, sedation and intubation. Future trials will also require standardization of care 
of these patients beyond the study intervention.  The lower-than-expected number of children 
with severe TBI and subsequent ICP monitor placement in the current study may also reflect the 
number of children in the cohort who had non- survivable injuries identified in the ED and 
therefore did not have ICP monitors placed. 
 
We found that one-half of all children with moderate-to-severe head injuries were transferred 
from another facility and that approximately one-half of children were present in the study ED 
within 2 hours of injury. The time lag between injury and arrival to the definitive treatment 
hospital is potentially concerning for future interventioal trials given the time-sensitive nature 
of many TBI therapies to be tested.  Of greater concern, however, is that only approximately 
one-half of legal guardians were present in the ED within 2-3 hours of their child’s injury. Our 
finding that most guardians of children transferred from other hospitals took 4-5 hours to arrive 
and that one-half of the children in our study were transferred is concerning given the time-
sensitive nature of  interventions in many TBI trials. Guardian arrival time starts the window in 
which written informed consent could be obtained. This has important implications for future
pediatric trials of therapies for TBI if these therapies have narrow windows of efficacy. In 
particular, delayed availability of a legal guardian argues for use of the Federal Exception from 
Informed Consent for Emergency Research in pediatric trials of TBI therapies. 11,12  Furthermore, 
even in cases where the guardian is at the bedside in a timely manner, the level of stress and 
anxiety over the critical condition of their children may preclude guardians from providing true 
informed consent. PECARN is currently conducting a trial ofsecond-line therapy in children 
with refractory status epilepticus using the Federal Exception from Informed Consent.32  
Although many of the patients’ guardians are present at the bedside, th  life threatening nature of 
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guardians makes it difficult to have a true informed consent discussion before initiating 
treatment. Similarly the ProTECT III trial of progesterone for TBI in adults was conducted sing 
EFIC.16 
 
The most common injury mechanisms in the study were MVCs. With this particular mechanism, 
many guardians may have been victims as well and taken to adult facilities for treatment. 
Furthermore, approximately one-half of the children in our study were transported from another 
hospital for definitive treatment and many ambulances do not allow guardians to travel with their 
children. Lack of guardian availability in the ED for children with TBIs has been demonstrated 
in other studies10, again arguing for EFIC.11 In the CRASH I trial (which included children older 
than 16 years of age) sites which had to obtain written informed consent took significantly longer 
to randomize patients and ultimately to administer study rug (3 hours versus 4 hours).33,34  
 
Our study also showed substantial heterogeneity of intra-cranial injuries among children with 
moderate-to-severe TBIs. The implications of this may be important, as certain interventions 
may target specific types of intracranial injuries. For example, progesterone has been shown to 
have several different mechanisms of action and, therefore, adult progesterone trials have 
typically enrolled patients with all types of intracranial injuries which could theoretically benefit 
from the actions of progesterone (recent negative trials notwithstanding).16,35  However, future 
trials of targeted therapies may need to enroll children with specific injury types, such as TXA 
for intracranial hemorrhage.36-40  In our cohort, intracranial hemorrhage was the most common 
type of brain injury on CT, accounting for approximately one-half of enrolled patients.   
 
Surprisingly, even after site PI review of enrolled patients (all with moderate-to-s vere TBIs) 
one-third of these children had normal initial CT scans. If future trials equire abnormal CT scans 
as an inclusion criterion, a substantial proportion of potentially eligible patients with normal 
initial CT scans may be missed. We did not evaluate, however, how many of these children had 
MRI or CT scans performed later which demonstrated serious injuries not apparent on the initial 
CT scans. In addition, it may take some time to determine the final, definitive CT interpretation 
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interpreted to determine eligibility for a TBI trial could significantly delay patient enrollment, 
and threaten administration of trial drug during the therapeutic window.  
 
This study had some limitations. We conducted the study using a waiver of informed consent; 
therefore, we didn’t approach parents to assess their willingness to consent to a future
interventional trial for TBI. In order to define who would be truly eligible we would have needed 
to intervene and reverse paralysis and sedation for each intubated patient to evaluate who had a 
GCS of 3 because of pharmacological sedation/paralysis rather than severe TBI. However, the 
need to get informed consent would bias our ability to capture all patients for the outcomes of 
interest. As a result, by using GCS alone, we likely overestimated the available number of 
children for a future TBI trial. In addition, we did not follow patients to document outcomes 
because of the same concerns about informed consent potentially biasing the main objectives of 
the study. Documenting outcomes of TBI was also beyond the scope of our study, in which the 
aim was to quantify the number of patients eligible for a future trial, and assess time of patient 
and guardian arrival in order to prepare for patient/guardian consent in future TBI trials. We 
were able to do this without consent, and captured all patients. Outcomes of moderate-severe 
TBI in children are known, and were not the focus here. In addition, although some patients were 
enrolled retrospectively, the limited dataset was highly objective (e.g. time of patient rrival, 
GCS score) and this allowed us to capture all eligible patients. We also found that some sites 
have no standardized documentation of parental presence. Therefore each site determined the 
best method for documenting this presence for their setting. This is a source of documentation 
that should be standardized across all pediatric trauma centers. 
 
 
Future trials of TBI in children will require inclusion of many high-enrolling sites, may require 
international collaboration, and will likely take several years to perform. However, if such 
definitive studies result in demonstrating novel therapies to be effective for the treatment of 
moderate-to-severe TBI in children, the costs and efforts will be greatly outweighed by the 
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In summary, we identified the number, timing of arrival, and important clinical and CT 
characteristics of potentially eligible children with moderate-to-severe TBIs for future clinical 
trials of novel therapeutic agents. Enrolling children with moderate-to-severe TBIs into clinical 
trials is challenging and will require large numbers of sites, meticulous preparation and 
coordination, and will prove challenging with regards to timing of patient and guardian arrival. 
Given these challenges, the F deral Exception from Informed Consent for Emergency Research 
will be an important consideration for timely enrollment of children into TBI clinical trials. 
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Number Enrolled 295 196 57 
Patient age in years 
(Median, Range) 
6.4 (0.1-17.9) 6.9 (0.1-17.9) 4.3 (0.1-17.9) 
Gender    
   Male 190 (64%) 124 (63%) 34 (60%) 
   Female 105 (36%) 72 (37%) 23 (40%) 
Race    
   White 162 (55%) 115 (59%) 26 (46%) 
   Black 65 (22%) 36 (18%) 18 (32%) 
   Other 20 (7%) 12 (6%) 3 (5%) 
   Unknown 48 (16%) 33 (17%) 10 (18%) 
Ethnicity    
   Hispanic 38 (13%) 24 (12%) 9 (16%) 
   Non-Hispanic 212 (72%) 144 (73%) 34 (60%) 
   Unknown 45 (15%) 28 (14%) 14 (25%) 
Mechanism of Injury    
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Fall 69 (23%) 29 (15%) 26 (46%) 
Pedestrian/Bike Injury 36 (12%) 23 (12%) 8 (14%) 
Assault 21 (7%) 17 (9%) 4 (7%) 
Sports Related 22 (7%) 11 (6%) 1 (2%) 
Other 20 (7%) 10 (5%) 6 (11%) 
Multiple 34 (12%) 28 (14%) 3 (5%) 
Unknown 5 (2%) 4 (2%) 0 (0%) 
Intubated at the time of 
best GCS in the ED 
180 (61%) 168 (86%) 12 (21%) 
Transfer from another 
hospital 
148 (50%) 113 (58%) 20 (35%) 
ICP Monitoring 67 (23%) 59 (30%) 8 (14%) 





Table 2.  Reasons for Potential Exclusions for Future Interventional Trial and Percentage of 
Patients that Met Each Criterion  
Reason N (%) 
Died in the ED 15 (5%) 
Cardiac arrest with CPR prior to arrival   35 (12%) 
Non survivable injury determined in ED   32 (11%) 
Spinal cord injury resulting in neurologic deficit 19 (6%)  
Hypotension (age-defined) 27 (9%) 
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Penetrating head injury 10 (3%) 
Potential abusive head trauma           17 (6%) 












Patients not transferred 






















0-1 hour 100 (35%)  59 (21%) 97 (69%) 57 (40%) 3 (2%) 2 (1%) 
>1-2 hours 161 (57%) 112 (39%) 133 (94%) 96 (68%) 28 (20%) 16 (11%) 
>2-3 hours 199 (70%) 145 (51%) 136 (96%) 107 (75%) 63 (44%) 38 (27%) 
>3-4 hours 228 (80%) 183 (64%) 138 (98%) 122 (86%) 90 (63%) 61 (43%) 
>4-5 hours 247 (87%) 212 (75%) 139 (99%) 127 (89%) 108 (76%) 85 (60%) 
>5-6 hours 262 (92%) 232 (82%) 139 (99%) 132 (93%) 123 (86%) 100 (70%) 






















Table 4.  Description of Types of Intracranial Injuries by CT  
Type of Injury N (%) 
Number of patients with CT scans 282 
Number of patients with normal ED CT scans 92 (32.6%) 
Total number of patients with any CT finding* 190 
Traumatic findings on CT  
Skull fracture 106 (55.8%) 
Subdural hematoma  75 (39.5%) 
Cerebral edema 56 (29.5%) 
Basilar skull fracture  51 (26.8%) 
Subarachnoid hemorrhage  48 (25.3%) 
Cerebral hemorrhage  33 (17.4%) 
Pneumocephalus 31 (16.3%) 
Midline shift /shift of brain structures 30 (15.8%) 
Cerebral contusion 26 (13.7%) 
Extra-axial hematoma 21 (11.1%) 
Epidural hematoma  17 (8.9%) 
Herniation 15 (7.9%) 
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Other traumatic findings# 18 (8.9%) 
* Of the 190 with CT findings, 44 had one finding and 146 had more than one finding                                
# Diffuse axonal injury (3.7%), Shear injury (1.6%), and Traumatic infarction (1.6%), Diastasis of the 
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ABSTRACT  10 
OBJECTIVES 11 
In preparation for a clinical trial of therapeutic agents for children with moderate-to-s vere blunt 12 
traumatic brain injuries (TBIs) in emergency departments (EDs), we conducted this feasibility 13 
study to 1) determine the number and clinical characteristics of eligible children, 2) determine 14 
the timing of patient and guardian arrival to the ED, and 3) describe the heterogeneity of TBIs on 15 
computed tomography (CT) scans. 16 
METHODS 17 
We conducted a prospective observational study at 16 EDs of children ≤ 18 years of age 18 
presenting with blunt head trauma and Glasgow Coma Scale (GCS) scores of 3-12.  We 19 
documented the number of potentially eligible patients, timing of patient and guardian arrival, 20 
patient demographics and clinical characteristics, severity of injuries, and cranial CT findings.  21 
RESULTS 22 
We enrolled 295 eligible children at the 16 sites over 6 consecutive months. Cardiac arrest and 23 
non-survivable injuries were the most common characteristics that would exclude patients from a 24 
future trial. Most children arrived within 2 hours of injury, but most guardians did not arrive until 25 
2-3 hours after the injury. There was a substantial range in types of TBIs, with subdural 26 
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CONCLUSION 28 
Enrolling children with moderate-to-severe TBI into time sensitive clinical trials will require 29 
large numbers of sites, meticulous preparation and coordination, and will prove challenging to 30 
obtain informed consent given the timing of patient and guardian arrival. The Federal Exception 31 
from Informed Consent for Emergency Research will be an important consideration for enrolling 32 
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Traumatic brain injury (TBI) is the leading cause of death and permanent disability from trauma 58 
in children.1,2  Among children 0-14 years in the United States, TBI results in an estimated 2,600 59 
deaths, 37,000 hospitalizations and more than 500,000 emergency department (ED) visits.3,4 60 
Despite the frequency of TBI, its substantial impact on the health of children, and decades of 61 
research on the topic, there are no proven effective treatments for TBI.5-7   62 
 63 
Many previous therapeutic trials for TBI in both children and adults have failed for several 64 
reasons, including: 1) the small number of patients with moderate-to-s vere TBI available to be 65 
studied at any one center, 2) the heterogeneity of TBIs, and difficulty in controlling for this 66 
heterogeneity, 3) the variability in intra- and inter-institutional approaches to the treatment of 67 
patients with TBIs, 4) the difficulty in enrolling subjects within the therapeutic window of a 68 
treatment, and 5) ethical and regulatory obstacles associated with research in emergency settings, 69 
including the difficulty in obtaining timely written informed consent.5-8  In addition, legal 70 
guardians are frequently not available in the narrow therapeutic window of potential therapies. 71 
Therefore, the Federal Exception from Informed Consent (EFIC) (21 CFR 50.24) may be 72 
necessary to study time sensitive interventions in a clinical trial.9-11  Pre-clinical work has shown 73 
that the sooner (many) therapies are delivered to patients with TBIs, the better the outcomes.  74 
There is an ongoing international multicenter pragmatic trial of tranexamic acid (TXA) for TBI 75 
in adults (CRASH III) where patients are randomized to TXA therapy within 8 hours of 76 
injury.12,13  In this international trial, patients who are incapable of giving consent in emergency 77 
situations are considered an exception to the general rule of informed consent per the Declaration 78 
of Helsinki.13,14 There have been other recent large interventional ED-based trials of 79 
progesterone for TBI in adults (ProTECT III and SyNAPSe) worth noting (and both were 80 
stopped for futility).15,16   In ProTECT III, study drug was administered to adult patients within a 81 
4-hour window using EFIC.15  There are several examples of pediatric TBI trials that failed to 82 
accrue sufficient numbers of children due to several factors such as limited numbers of eligible 83 
children at any one site, difficulties with informed consent, and arrival of subjects outside the 84 
therapeutic window of the study intervention.5,8  The obstacles to successful pediatric TBI trials 85 
have not been sufficiently addressed or overcome. Given the history of prior unsuccessful 86 
pediatric TBI trials, it is necessary to conduct pretrial feasibility planning work to maximize the 87 
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 89 
Conducting large clinical trials in head-injured children is difficult and requires a 90 
multidisciplinary approach.5,17  The Pediatric Emergency Care Applied Research Network 91 
(PECARN) was established to overcome the barriers of conducting research pertaining to acutely 92 
ill and injured children during all phases of emergency care and has a history of successful 93 
completion of large multicenter clinical trials.18-25  Due to the promising pre-clinical and phase II 94 
studies for the use of progesterone for adult TBI, PECARN investigators were funded to conduct 95 
feasibility planning for a clinical trial of progesterone and other promising agents for TBI in 96 
children.26  In this manuscript we report a prospective observational feasibility study of children 97 
with moderate-to-severe TBI presenting to 16 pediatric EDs across the US.  98 
The goals of this study were to 1) determine the number and clinical characteristics of children 99 
with moderate-to-severe TBI at each participating site, 2) determine the timing of patient and 100 
guardian arrival to the ED to provide informed consent within the therapeutic windows of 101 
different interventions, and 3) describe the heterogeneity of TBIs on computed tomography (CT) 102 
scans.  103 
 104 
METHODS 105 
Study design and setting 106 
We conducted a prospective observational study at 16 level-one pediatric trauma center EDs in 107 
PECARN. During the 9-month study period (July 2011 – Mar 2012) each site collected data on 108 
all potential eligible patients for 6 consecutive months.  109 
Population 110 
We prospectively enrolled children up to their 18th birthdays who presented to the ED after blunt 111 
head trauma with Glasgow Coma Scale (GCS) scores of 3-12 (i.e. moderate-to-sev re TBI). 112 
Study data collection 113 
We collected clinical data using a study case report form including information about patient 114 
demographics, mechanisms of injury, clinical presentation including GCS, and time of arrival of 115 
patient and legal guardian.  (See appendix 1 study case report form) All site PIs and research 116 
coordinators were trained on study methods using a combination of web-based presentations and 117 
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Clinicians and research staff completed most case report formd prospectively.  To minimize 120 
missed enrollment of eligible children, research staff screened daily for all patients with blunt 121 
head trauma and GCS scores of 3-12, then identified and retrospectively enrolled eligible 122 
children who had been missed. Physicians and research coordinators also recorded time of arrival 123 
of legally-authorized guardians.  The purpose of recording guardian arrival time was to estimate 124 
a time window in which written informed consent could likely be obtained from a guardian in a 125 
future interventional trial.  We asked site investigators to identify the best way to record the time 126 
of arrival of the legal guardian in advance of study initiation.  Some sites recorded time of arrival 127 
from their trauma record and other sites used the time of arrival as recorded by social work.  The 128 
site principal investigator (PI) or research staff member obtained the information from the 129 
treating clinician or from the medical records and did not approach the parent or patient for any 130 
information. Site research coordinators entered the data into an electronic data capture system 131 
maintained at the PECARN data center at the University of Utah.  132 
 133 
To determine the spectrum of TBIs, each site submitted cranial CT findings for each patient 134 
enrolled in the study. The study PIs (RS, NK) reviewed radiology reports, classified and 135 
adjudicated study CT findings.  For children with normal cranial CT scans, we asked site PIs to 136 
verify whether there was indeed a history of blunt head trauma; if there was no history of head 137 
trauma, these children were excluded from the database. Three children met this exclusion 138 
criterion. 139 
 140 
Study definitions  141 
In this analysis we used the following study definitions: 142 
 Best GCS score:  This was the best GCS that the patient had during their ED stay; 143 
 Moderate TBI: GCS 9-12 inclusive;  144 
 Severe TBI: GCS 3-8 inclusive;  145 
 Non-survivable injury: This was based on the clinical judgment of the ED treating 146 
physician;  147 
 Hypotension: Documented systolic blood pressure (SBP) below 90mmHg for patients > 148 
10 years, <70mmHg + (age in years x 2) for patients 1- 10 years and < 70mmHg for 149 
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 Hypoxia: Documented oxygen saturation of < 90% for at least 15 consecutive minutes; 151 
 Potential Abusive Head Trauma: Assault documented as the mechanism of injury in a 152 
patient < 3 years-old. 153 
 154 
Human subjects protection 155 
As this was a minimal risk study, and because it was not practical to request informed consent 156 
from each patient, we requested a waiver of informed consent. There was no interaction with the 157 
patients or guardians, and the scientific validity of the study was dependent on capturing the 158 
information from the entire population of children with moderate-to-severe TBI at each 159 
participating site. We gathered information both prospectively and retrospectively (for missed 160 
patients).  161 
 162 
Data analysis 163 
We prepared data summaries using SAS software (version 9.4, SAS Institute Inc., Cary, NC). 164 
 165 
RESULTS 166 
We enrolled 295 children with blunt head trauma and GCS scores of 3-12 during the study 167 
period at the 16 EDs.  All eligible patients were captured. The cumulative total of all pediatric 168 
ED visits to the 16 participating EDs during the study period was approximately 483,426. 169 
 170 
Table 1 describes patient demographics and mechanisms of injury, stratified by best GCS score 171 
in the ED. Of note, most enrolled patients were boys, and motor vehicle collisions (MVCs) were 172 
the most common mechanism of injury.  One-half of the patients were transferred from another 173 
hospital to the participating ED. Of note, 180 (61%) children were intubated at the time of the 174 
best GCS in the ED, making neurological assessment difficult. 175 
In addition, 23% (67/295) of enrolled children received intracranial pressure (ICP) monitoring, 176 
including only one-third (59/196) of the severely injured. 177 
 178 
We enrolled between 5 and 34 patients per ED over the 6-month period. Figure 1 shows the 179 
overall ED volume of each site over the 6-month study period and numbers of patients enrolled 180 
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institutions.  Importantly, 77 (26%) of the 295 head-injured children in our study met one or 182 
more potential exclusion criteria for a future trial of TBI therapy.3,6  Clinical characteristics that 183 
would make patients potentially ineligible for a future TBI trial are described in Table 2. The 184 
most common among these were cardiac arrest requiring cardiopulmonary resuscitation (CPR) 185 
prior to arrival to the ED and non-survivable injury determined in the ED. Age-adjusted 186 
hypotension was noted in 9% of patients, hypoxia in 4% and potential abusive head trauma in 6 187 
% (as noted by the mechanism “assault” for children younger than 3 years).  188 
  189 
Table 3 shows the timing of arrival of the child and the legal guardian after the time of injury.  190 
This result was stratified by whether the child was transferred from another hospital to the 191 
PECARN hospital, or whether the child arrived from the field to the PECARN hospital. Overall 192 
most children with TBIs arrived within 1-2 hours of their injuries, however, most 193 
parents/guardians did not arrive until 2-3 hours or later after the injury (and some guardians 194 
[n=8; 3%] did not arrive at all).  Of importance, 50% of children were transferred from another 195 
hospital and only 44% of transferred children arrived within 2-3 hours of their injury; most of 196 
their guardians did not arrive until 4-5 hours after injury, which has substantial implications for 197 
informed consent for time-sensitive therapies. We also looked at timing of guardian arrival based 198 
on mechanism of injury and GCS score and we found that a higher percentage of guardians 199 
arrived 3 or more hours after injury for the more severely injured children and for children 200 
involved in MVCs. 201 
 202 
The description and distribution of TBIs on CT are provided in Table 4. There was great 203 
heterogeneity in types of TBIs, with subdural hemorrhage being the most common intra-cranial 204 
injury, followed by subarachnoid hemorrhage. Of note, one-third of CT scans were normal. 205 
 206 
DISCUSSION  207 
In this study we documented the number of children with moderate-to-s vere TBIs presenting to 208 
individual EDs in PECARN and demonstrated great variation in numbers between sites. In 209 
addition, up to one-quarter of these children might be excluded from a clinical trial because they 210 
met potential exclusion criteria. When we considered only those children with severe TBIs, less 211 
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between the time of the patients’ arrival and that of their guardians, with most patients arriving in 213 
the treating ED within 1-2 hours of their injuries and most guardians not arriving 2-3 hours or 214 
later after the injuries. Importantly, guardians of children who were transferred from other 215 
hospitals took twice as long to arrive to the study hospitals than non-transferred children’s’ 216 
guardians. We also showed great heterogeneity of TBIs on CT and up to one-third of children 217 
had normal initial CT scans. 218 
 219 
Notably, we also found that the number of potential future study patients does not correlate with 220 
total ED patient volume, highlighting the differences in the types of patients seen between 221 
pediatric EDs. There was substantial variation in the numbers of patients with moderate-to-222 
severe TBI presenting to individual pediatric trauma centers and this variation was not related to 223 
overall ED volume. This demonstrates that site selection is critical to reach adequate sample 224 
sizes in future interventional trials of TBI in children. This issue may partially account for the 225 
lack of adequate patient accrual in prior pediatric TBI trials.5-8   226 
 227 
We collected data on controversial potential exclusion criteria for pediatric TBI trials (Table 2). 228 
These include age-adjusted hypotension, hypoxia and suspected abusive head trauma. Prior 229 
studies have typically excluded children with these conditions for fear of biasing the sample 230 
given that outcomes after TBI have been shown to be worse after a single episode of hypotension 231 
or hypoxia.5,8,27  The patient history in children with suspected abusive head trauma may be 232 
unreliable, and it may not be possible to accurately determine the time of injury. Despite these 233 
issues, and given both the lack of any proven effective treatments for pediatric TBI and the 234 
number of children with TBIs who suffer from hypotension, hypoxia or abusive head trauma, 235 
one may argue about the ethics of excluding these children from a future clinical trial of a 236 
promising therapeutic agent for TBI.  237 
 238 
Published guidelines recommend ICP monitoring for the management of children with severe 239 
TBIs.28   In the current study, however, we found that less than one-third of children presenting 240 
to the ED with GCS scores of 8 or less subsequently had ICP monitors placed during their 241 
hospital stay.  Prior studies have shown significant between-site variations in ICP monitor 242 
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study may reflect that head-injured children with low GCS scores due to intubation with 244 
pharmacological sedation and paralysis may have been found not to have severe TBI when the 245 
sedation and paralysis were reversed; the relative infrequency of ICP monitor use may also 246 
reflect practice variation between physicians. Therefore, in future pediatric TBI clinical trials 247 
conducted in the ED it may be important to consider timely reversal of paralysis and sedation to 248 
determine the true GCS score, or to accurately determine the GCS score in the prehospital setting 249 
prior to paralysis, sedation and intubation.  Future trials will also require standardization of care 250 
of these patients beyond the study intervention. The lower-than-expected number of children 251 
with severe TBI and subsequent ICP monitor placement in the current study may also reflect the 252 
number of children in the cohort who had non- survivable injuries identified in the ED and 253 
therefore did not have ICP monitors placed. 254 
 255 
We found that one-half of all children with moderate-to-severe head injuries were transferred 256 
from another facility and that approximately one-half of children were present in the study ED 257 
within 2 hours of injury. The time lag between injury and arrival to the definitive treatment 258 
hospital is potentially concerning for future interventional trials given the time-sensitive nature 259 
of many TBI therapies to be tested.  Of greater concern, however, is that only approximately 260 
one-half of legal guardians were present in the ED within 2-3 hours of their child’s injury. Our 261 
finding that most guardians of children transferred from other hospitals took 4-5 hours to arrive 262 
and that one-half of the children in our study were transferred is concerning given the time-263 
sensitive nature of interventions in many TBI trials. Guardian arrival time starts the window in 264 
which written informed consent could be obtained. This has important implications for future 265 
pediatric trials of therapies for TBI if these therapies have narrow windows of efficacy. In 266 
particular, delayed availability of a legal guardian argues for use of EFIC in pediatric trials of 267 
TBI therapies. 10,11  Furthermore, even in cases where the guardian is at the bedside in a timely 268 
manner, the level of stress and anxiety over the critical condition of their children may preclude 269 
guardians from providing true informed consent. PECARN is currently conducting a trial of 270 
second-line therapy in children with refractory status epilepticus using EFIC.30  Although many 271 
of the patients’ guardians are present at the bedside, the life threatening nature of status 272 
epilepticus, the need for timely treatment and the level of stress and anxiety among guardians 273 
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Similarly the ProTECT III trial of progesterone for TBI in adults was conducted using the 275 
EFIC.15 276 
 277 
The most common injury mechanisms in the study were MVCs. With this particular mechanism, 278 
many guardians may have been victims as well and taken to adult facilities for treatment. 279 
Furthermore, approximately one-half of the children in our study were transported from another 280 
hospital for definitive treatment and many ambulances do not allow guardians to travel with their 281 
children. Lack of guardian availability in the ED for children with TBIs has been demonstrated 282 
in other studies9, again arguing for EFIC.10 In the CRASH I trial (which included children older 283 
than 16 years of age) sites which had to obtain written informed consent took significantly longer 284 
to randomize patients and ultimately to administer study drug (3 hours versus 4 hours).31,32  285 
 286 
Our study also showed substantial heterogeneity of intra-cranial injuries among children with 287 
moderate-to-severe TBIs. The implications of this may be important, as certain interventions 288 
may target specific types of intracranial injuries. For example, progesterone has been shown to 289 
have several different mechanisms of action and, therefore, adult progesterone trials have 290 
typically enrolled patients with all types of intracranial injuries which could theoretically benefit 291 
from the actions of progesterone (recent negative trials notwithstanding).15,33  However, future 292 
trials of targeted therapies may need to enroll children with specific injury types, such as TXA 293 
for intracranial hemorrhage.34-38  In our cohort, intracranial hemorrhage was the most common 294 
type of brain injury on CT, accounting for approximately one-half of enrolled patients.   295 
 296 
Surprisingly, even after site PI review of enrolled patients (all with moderate-to-s vere TBIs) 297 
one-third of these children had normal initial CT scans. If future trials require abnormal CT scans 298 
as an inclusion criterion a substantial proportion of potentially eligible patients with initial 299 
normal CT scans may be missed. We did not evaluate, however, how many of these children had 300 
MRI or CT scans performed later which demonstrated serious injuries not apparent on the initial 301 
CT scans. In addition, it may take some time to determine the final, definitive CT interpretation 302 
when a child presents to the ED with TBI. Therefore, waiting for the CT scan to be definitively 303 
interpreted to determine eligibility for a TBI trial could significantly delay patient enrollment, 304 
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 306 
This study had some limitations. We conducted the study using a waiver of informed consent; 307 
therefore, we didn’t approach parents to assess their willingness to consent to a future 308 
interventional trial for TBI. In order to define who would be truly eligible we would have needed 309 
to intervene and reverse paralysis and sedation for each intubated patient to evaluate who had a 310 
GCS of 3 because of pharmacological sedation/paralysis rather than severe TBI. However, the 311 
need to get informed consent would bias our ability to capture all patients for the outcomes of 312 
interest. As a result, by using GCS alone we likely overestimated the available number of 313 
children for a future TBI trial. In addition, we did not follow patients to document outcomes 314 
because of the same concerns about informed consent potentially biasing the main objectives of 315 
the study. Documenting outcomes of TBI was also beyond the scope of our study, in which the 316 
aim was to quantify the number of patients eligible for a future trial, and assess time of patient 317 
and guardian arrival in order to prepare for patient/guardian consent in future TBI trials. We 318 
were able to do this without consent, and captured all patients. Outcomes of moderate-severe 319 
TBI in children are known, and were not the focus here. In addition, although some patients were 320 
enrolled retrospectively, the limited dataset was highly objective (e.g. time of patient arrival, 321 
GCS score) and this allowed us to capture all eligible patients. We also found that some sites 322 
have no standardized documentation of parental presence. Therefore each site determined the 323 
best method for documenting this presence for their setting. This is a source of documentation 324 
that should be standardized across all pediatric trauma centers. 325 
 326 
 327 
Future trials of TBI in children will require inclusion of many high-enrolling sites, may require 328 
international collaboration, and will likely take several years to perform. However, if such 329 
definitive studies result in demonstrating novel therapies to be effective for the treatment of 330 
moderate-to-severe TBI in children, the costs and efforts will be greatly outweighed by the 331 
reduction of morbidity and mortality, and quality life-years saved.  332 
 333 
CONCLUSIONS 334 
In summary, we identified the number, timing of arrival, and important clinical and CT 335 
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trials of novel therapeutic agents. Enrolling children with moderate-to-s vere TBIs into clinical 337 
trials is challenging and will require large numbers of sites, meticulous preparation and 338 
coordination, and will prove challenging with regards to timing of patient and guardian arrival. 339 
Given these challenges, the Federal Exception from Informed Consent for Emergency Research 340 
will be an important consideration for timely enrollment of children into TBI clinical trials. 341 
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Best GCS 3-8 
Severe TBI 
Best GCS 9-12 
Moderate TBI 
Number Enrolled 295 196 57 
Patient age in years 
(Median, Range) 
6.4 (0.1-17.9) 6.9 (0.1-17.9) 4.3 (0.1-17.9) 
Gender    
   Male 190 (64%) 124 (63%) 34 (60%) 
   Female 105 (36%) 72 (37%) 23 (40%) 
Race    
   White 162 (55%) 115 (59%) 26 (46%) 
   Black 65 (22%) 36 (18%) 18 (32%) 
   Other 20 (7%) 12 (6%) 3 (5%) 
   Unknown 48 (16%) 33 (17%) 10 (18%) 
Ethnicity    
   Hispanic 38 (13%) 24 (12%) 9 (16%) 
   Non-Hispanic 212 (72%) 144 (73%) 34 (60%) 
   Unknown 45 (15%) 28 (14%) 14 (25%) 
Mechanism of Injury    
MVC  88 (30%) 74 (38%) 9 (16%) 
Fall 69 (23%) 29 (15%) 26 (46%) 
Pedestrian/Bike Injury 36 (12%) 23 (12%) 8 (14%) 
Assault 21 (7%) 17 (9%) 4 (7%) 
Sports Related 22 (7%) 11 (6%) 1 (2%) 
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Multiple 34 (12%) 28 (14%) 3 (5%) 
Unknown 5 (2%) 4 (2%) 0 (0%) 
Intubated at the time of 
best GCS in the ED 
180 (61%) 168 (86%) 12 (21%) 
Transfer from another 
hospital 
148 (50%) 113 (58%) 20 (35%) 
ICP Monitoring 67 (23%) 59 (30%) 8 (14%) 
MRI Obtained 89 (30%) 70 (36%) 13 (23%) 
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Table 2.  Reasons for Potential Exclusions for Future Interventional Trial and Percentage of 
Patients that Met Each Criterion  
Reason N (%) 
Died in the ED 15 (5%) 
Cardiac arrest with CPR prior to arrival   35 (12%) 
Non survivable injury determined in ED   32 (11%) 
Spinal cord injury resulting in neurologic deficit 19 (6%)  
Hypotension (age-defined) 27 (9%) 
Hypoxia (O2 sat < 90% for > 15 mins) 11 (4%) 
Penetrating head injury 10 (3%) 
Potential abusive head trauma           17 (6%) 
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Patients not transferred 






















0-1 hour 100 (35%)  59 (21%) 97 (69%) 57 (40%) 3 (2%) 2 (1%) 
>1-2 hours 161 (57%) 112 (39%) 133 (94%) 96 (68%) 28 (20%) 16 (11%) 
>2-3 hours 199 (70%) 145 (51%) 136 (96%) 107 (75%) 63 (44%) 38 (27%) 
>3-4 hours 228 (80%) 183 (64%) 138 (98%) 122 (86%) 90 (63%) 61 (43%) 
>4-5 hours 247 (87%) 212 (75%) 139 (99%) 127 (89%) 108 (76%) 85 (60%) 
>5-6 hours 262 (92%) 232 (82%) 139 (99%) 132 (93%) 123 (86%) 100 (70%) 
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Table 4.  Description of Types of Intracranial Injuries by CT  
Type of Injury N (%) 
Number of patients with CT scans 282 
Number with normal ED CT scans 92 (32.6%) 
Total number of patients with any CT finding* 190 
Traumatic findings on CT  
Skull fracture 106 (55.8%) 
Subdural hematoma  75 (39.5%) 
Cerebral edema 56 (29.5%) 
Basilar skull fracture  51 (26.8%) 
Subarachnoid hemorrhage  48 (25.3%) 
Cerebral hemorrhage  33 (17.4%) 
Pneumocephalus 31 (16.3%) 
Midline shift /shift of brain structures 30 (15.8%) 
Cerebral contusion 26 (13.7%) 
Extra-axial hematoma 21 (11.1%) 
Epidural hematoma  17 (8.9%) 
Herniation 15 (7.9%) 
Intraventricular hemorrhage 14 (7.4%) 
Other traumatic findings# 18 (8.9%) 
* Of the 190 with CT findings, 44 had one finding and 146 had more than one finding                                
# Diffuse axonal injury (3.7%), Shear injury (1.6%), and Traumatic infarction (1.6%), Diastasis of the 
skull (0.5%) and other 
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